AI-generated summary
The authors randomized 58 people with subjective cognitive decline to real or sham transcranial brain photobiomodulation for six consecutive days, recording sleep and working memory on n-back tasks. They report no between-group difference in sleep efficiency, REM percentage or wake-up time, but better n-back accuracy and reaction time in the real-light group. The abstract does not state the trial's long-term effects or clinical significance.
- Participants
- 58
- Who or what was studied
- Adults with subjective cognitive decline
- Limits stated in the abstract
- The abstract reports no between-group sleep differences overall, and the sleep improvements were seen only within the real-light group on day five.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Cognitive decline, Sham, Control group, Biomarker. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.